Arabian International Healthcare Holding Company

TADAWUL:9530.SR

34 (SAR) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q42024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 540.328137.048137.048490.962245.481315.962157.981427.461213.717215.239107.62369.301184.651249.239124.619625.043312.521193.64696.823
Cost of Revenue 415.059106.312106.312369.65181.916257.1126.528314.061157.009174.43987.246283.507141.754191.51495.757465.604232.802154.70577.353
Gross Profit 125.26930.73730.737121.31263.56558.86231.453113.456.70740.820.37385.79442.89757.72528.862159.43979.71938.94119.471
Gross Profit Ratio 0.2320.2240.2240.2470.2590.1860.1990.2650.2650.190.1890.2320.2320.2320.2320.2550.2550.2010.201
Reseach & Development Expenses 0000000000000000000
General & Administrative Expenses 016.36116.36115.91215.91213.44213.44211.77411.7749.6679.6676.3166.3167.9657.9657.8227.8227.9557.955
Selling & Marketing Expenses 019.21419.21420.05720.05718.98218.98217.02917.02918.34218.34216.06216.06215.13715.13716.77616.77616.01916.019
SG&A 79.59638.97738.97771.86938.84461.58732.81656.52926.23557.71828.83225.09312.54748.32824.16450.1725.08549.92524.962
Other Expenses 010.10110.10100005.14600000000000
Operating Expenses 79.59649.07849.07871.86920.61361.58731.91351.38224.46257.71825.42325.0931.65248.32820.04350.173.78449.92524.429
Operating Income 45.673-18.341-18.34149.44429.466-2.7250.44662.01833.298-16.918-6.50660.70134.4079.3966.14109.26854.408-10.983-3.835
Operating Income Ratio 0.085-0.134-0.1340.1010.12-0.0090.0030.1450.156-0.079-0.060.1640.1860.0380.0490.1750.174-0.057-0.04
Total Other Income Expenses Net -74.4464.7694.76921.38414.808-14.735-7.88116.26-9.946-0.173-2.0414.816-3.905-2.675-2.77922.576-5.09-9.228-6.27
Income Before Tax -28.773-13.572-13.57270.82834.274-14.87-7.31351.59125.385-17.091-7.08975.51740.8216.7226.048131.84571.124-20.211-11.229
Income Before Tax Ratio -0.053-0.099-0.0990.1440.14-0.047-0.0460.1210.119-0.079-0.0660.2040.2210.0270.0490.2110.228-0.104-0.116
Income Tax Expense 3.6373.0053.0056.7073.3534.8672.4344.42.1936.53.254.4242.21273.515.57.758.54.25
Net Income -34.799-15.907-15.90760.88930.445-22.801-11.40152.07820.576-20.678-10.33977.21838.6095.0962.548126.74863.374-30.958-15.479
Net Income Ratio -0.064-0.116-0.1160.1240.124-0.072-0.0720.1220.096-0.096-0.0960.2090.2090.020.020.2030.203-0.16-0.16
EPS -1.76-0.8-0.83.081.54-1.15-0.582.321.03-1.03-0.523.861.930.250.136.3424.72-1.55-309.58
EPS Diluted -1.76-0.8-0.83.081.54-1.15-0.581.031.03-1.03-0.523.861.930.250.136.3424.72-1.55-309.58
EBITDA 4.387-3.353-3.353103.92732.6257.1792.02166.81234.107-9.639-4.8286.89735.62615.9447.972145.66654.566-3.782-1.891
EBITDA Ratio 0.008-0.024-0.0240.2120.1330.0230.0130.1560.16-0.045-0.0450.2350.1930.0640.0640.2330.175-0.02-0.02